• Slider Image
  • Slider Image
  • Slider Image

In the Press


February 22, 2015

CIRM's Klein proposes $100B biomed program: Bob Klein describes his vision of how to increase biomedical funding to hasten discovery and commercialization of disease treatments. He spoke Thursday, Feb. 19, at the annual UCSD Moores Cancer Center symposium.
» San Diego Union Tribune article


February 21, 2015

Fighting patient, fighting doctor: : Patient Theresa Blanda speaks about her experience battling cancer with the help of Moores Cancer Center Investigator Dr. Catriona Jamieson, at the 11th annual Industry/Academia Translational Oncology Symposium.
» San Diego Union Tribune article


February 19, 2015

Katherine Connor from the San Diego Daily Transcript reports on the new funding paradigm needed for scientific research: Some of the nation’s top oncology researchers and private companies in the cancer space met at the University of California, San Diego Moores Cancer Center Thursday for the 11th annual Industry/Academic Translational Oncology Symposium.
» San Diego Daily Transcript article


February 13, 2015

The Union-Tribune published an opinion editorial by Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD, entitled "Finding Ways to create cancer-killing swords". The op-ed features the upcoming 11th Annual Moores Cancer Center Industry/Academia Translational Oncology Symposium on February 19, and the ongoing collaborations at MCC.
» Union Tribune Op-ed


January 12, 2015

Trovagene Collaborates with UC San Diego Moores Cancer Center to Demonstrate Clinical Utility of Detecting and Monitoring EGFR Mutations in Lung Cancer Patients. The lead investigator in the study is Assistant Professor of Hematology-Oncology Dr. Hatim Husain.
» Press Release


February 18, 2014

San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and upcoming Symposium. The I-SPY Clinical Trial is lead by Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA.
» Full Video and Article


» More Press




Stay Updated





2015 Symposium:


Our 11th Annual Moores Cancer Center Industry/Academia Translational Oncology Symposium took place on Thursday February 19, 2015.

Featured speakers:

Keynote Speaker
Cancer Genomics: Turning Discovery into Translation

Elaine Mardis, PhD

The Genome Institute
Washington University School of Medicine

Keynote Speaker
Imatinib as a Paradigm of Molecularly Targeted Cancer Therapies

Brian Druker, MD

OHSU Knight Cancer Institute


Duane Roth Award

Presented by Congressman Scott Peters

Congressman Scott Peters serves California'a 52nd Congressional District, which includes the cities of Coronado, Poway, and most of northern San Diego. First elected in 2012, he currently serves on the House committees on Armed Services & on Science, Space, & Technology Committee.


A novel bispecific antibody targeting EGFR and cMet with multiple mechanisms of action

Mark Anderson, PhD

Scientific Director
Janssen Pharmaceuticals

Advancing the Utility of Clinic Sequencing for MDS

Rafael Bejar, MD, PhD

Moores Cancer Center

Welcome and Overview

David Brenner, MD

UCSD School of Medicine

Reversing Drug Resistance in Cancer Stemness

David Cheresh, PhD

Moores Cancer Center

Napoleon in Rags and the Language that he Used: the New World of Immunotherapy in Head and Neck Cancer

Ezra Cohen, MD

Moores Cancer Center

Targeting tumor-associated inflammation in cancer

Lisa Coussens, PhD

OHSU Knight Cancer Institute

Melanoma Patients Path: Translations to the Clinic

Gregory Daniels, MD

Moores Cancer Center

Combining VEGF inhibitors with strategies to manipulate the immune system in cancer

Napoleone Ferrara, MD

Moores Cancer Center

ePatients on the Front Lines: Precision Medicine, the FDA, and Me

Janet Freeman-Daily

Patient Advocacy

The Cancer Cell Map Initiative (CCMI) - Mapping the hallmark networks of cancer

Trey Ideker, PhD

UC San Diego

Bringing Btk inhibition forward

Danelle James, MD, MAS

Head of Oncology
Pharmacyclics

Preclinical and Clinical Cancer Stem Cell Detection and Elimination

Catriona Jamieson, MD, PhD

Moores Cancer Center

Welcome and Overview

Pradeep Khosla, PhD

UC San Diego

Drugging the Undrugable: KRAS

D. Lynn Kirkpatrick, PhD

President and Chief Executive Officer
PHusis Therapeutics Inc.

Finding the Money to Fund Translational Research

Bob Klein

President, Founder, and CEO
Klein Financial Corporation

Welcome and Overview

Scott Lippman, MD

Moores Cancer Center

CIRM 2.0. Building a better stem cell agency

C. Randal Mills, PhD

President and Chief Executive Officer
California Institute for Regenerative Medicine

A More Beautiful Question

Brad Perkins, MD

Chief Medical Officer
Human Longevity, Inc.

Engineering the immune system with chimeric antigen receptors to eradicate cancer

Margo Roberts, PhD

Chief Scientific Officer
Kite Pharma

Development of Next Generation Angiogenesis Inhibitors

Charles Theuer, MD, PhD

Chief Executive Officer
TRACON Pharmaceuticals

Targeting PI3Kgamma and BTK to suppress tumor-associated inflammation

Judith Varner, PhD

Moores Cancer Center


Take a look at the speaker bios and more information.


2014 Translational Oncology Symposium

A decade of fostering collaborations, fueling innovation & saving lives



San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and Symposium. The I-SPY Clinical Trial is lead by Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA. For the video, see below.



The article is available here.

  • Xconomy’s San Diego Life Sciences Roundup included Bob Klein’s Proposal presented at the Moores Cancer Center Symposium, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016.
         » Read Here
  • Xconomy's San Diego Life Sciences Roundup also included the Moores Cancer Center Symposium and Laura Esserman's acceptance of the Duane Roth Award.
         » Read Here
  • The San Diego Daily Transcript published an article about Dr. Esserman's acceptance of the Duane Roth Award and the Symposium.
         » Read Here
  • The San Diego Union Tribune wrote an article on the Symposium, namely the iSPY Trial and patient from the trial, San Diego Resident Heather Clark.
         » Read Here
  • Symposium Speaker Bob Klein was featured in a San Diego Union Tribune article, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016, presented at the Moores Cancer Center Symposium.
         » Read Here


Our Symposium Page




Spotlight: Principal Investigators


Learn more about our Principal Investigators here at Moores Cancer Center, including their Translational Oncology Research and toolbox of models they use. For all interviews, please see the Principal Investigators page.


Olivier Harismendy, PhD, Assistant Professor of Pediatrics, Department of Pediatrics

Dr. Harismendy has a decade of experience in functional genomics and has been working in translational genomics for the past six years, developing assays and analysis for targeted sequencing, exploring the role of regulatory variants in common diseases, and improving the detection of somatic mutations in cancer. Most recently, he has been implementing an Ultra Deep Targeted Sequencing assay to detect low-prevalence mutations in clinical samples, with the intent of advancing research to ultimately provide a comprehensive personalized molecular profile of solid tumors.

David Cheresh, PhD, Professor of Medicine, Associate Director for Research Education and Training

Dr. Howell is a tenured Professor of Medicine with more than 35 years of experience as a principal investigator in basic science, translational research, and both investigator-initiated and industry-initiated clinical research. Over the past decade, he has focused on understanding the cellular pharmacology of platinum drugs, a class of chemotherapy drugs that trigger cell death in cancerous tumors, and the development of additional drug delivery systems for platinum-containing chemotherapeutic agents.

David Vera, PhD, Professor of Radiology and Surgery, Co-Director, UCSD Molecular Imaging Program

Dr. Vera's principal focus is the design and synthesis of targeted diagnostic agents capable of measuring receptor density and affinity. His current research uses receptor-binding technology for sentinel node mapping of melanoma, breast, GI, and urologic cancers. The new agent, Tc-99m-DTPA-mannosyl-dextran (also called Lymphoseek or the generic name, tilmanocept), developed in collaboration with UCSD clinicians and surgeons, recently completed in a Phase III multi-center clinical trial for breast cancer and melanoma.

Rafael Bejar, MD, PhD, Assistant Professor of Medicine, Division of Hematology-Oncology

Dr. Bejar is Assistant Professor of Medicine in the Division of Hematology-Oncology. His lab is focused on understanding the genetic changes that drive the development and progression of hematologic malignancies like acute myeloid leukemia and myelodysplastic syndromes. His goal is to translate discoveries into clinically meaningful improvements in patient care with these disorders.


Michael Choi, MD, Assistant Clinical Professor, Division of Hematology-Oncology

Dr. Choi is a hematologist and medical oncologist specializing in the treatment of patients with blood cancers and other blood disorders, with an emphasis on chronic lymphocytic leukemia (CLL). He is a part of UC San Diego's CLL research team, collaborating with the laboratories of Drs. Thomas Kipps, Januario Castro, and Dennis Carson to help develop new therapies for patients with blood cancers. His clinical research interests include highly targeted novel therapies that can be used to treat blood cancers in a personalize and molecularly-driven manner.

More Video Interviews



9th Symposium Featured on San Diego ABC 10 News




San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Linda Lowe, a patient of Moores Cancer Center Investigator Dr. Catriona Jamieson, along with Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD , in a video report from the 6PM News on April 11 covering the successful 9th Industry/Academia Translational Oncology Symposium.

More In the Press